EN DE
STOCK COMPARISON

Genetics Generation Advancement vs Thermo Fisher Scientific: Fair Value & Quality

Both stocks run through our valuation models. Here is how Genetics Generation Advancement (4160) and Thermo Fisher Scientific (TMO) compare, as of Sep 25, 2026.

As of Sep 25, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the more attractively valued of the two: Genetics Generation Advancement trades at TWD 39.45 versus a fair value of TWD 13.61 (-66%), while Thermo Fisher Scientific trades at $665 versus $683 (+3%).
Genetics Generation Advancement
4160.TWO · TWD · Consumer Staples
-66%
upside to fair value
overvalued
PriceTWD 39.45
Fair ValueTWD 13.61
Quality37/100
Thermo Fisher Scientific
TMO · USD · Health Care
+3%
upside to fair value
fairly valued
Price$665
Fair Value$683
Quality62/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Genetics Generation AdvancementThermo Fisher Scientific
Valuation
59.3×P/E (TTM)36.6×
1.73×P/S (TTM)5.55×
1.76×P/B4.70× · book value is mostly goodwill
48.1×EV/EBITDA24.5×
n/aPEG1.74×
−65.5%Fair value upside+2.6%
4.6%Dividend yield0.3%
n/aDividend per share$1.76
Profitability
0%Operating margin18%
n/aEBIT margin trend (5Y)0.74×
4%Return on equity14%
0%Return on assets5%
Growth
4%Revenue growth (YoY)6%
3.3%Avg. growth/yr (3Y)-0.3%
n/aAvg. growth/yr (5Y)6.7%
+26.8%Value creation/yr+2.6%
Balance & size
20.0×Interest coverage (EBIT/interest)5.7×
n/aDebt / equity0.67×
$33MMarket cap$251B
expensiveGrowth qualityhealthy
Valuation multiples (P/E, P/S, P/B, EV/EBITDA) are shown but not scored here: the two companies sit in different sectors, and multiples only compare fairly between similar business models. PEG stays scored, as it relates the P/E to growth.

Even match: 4 to 4 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Genetics Generation Advancementof which business quality 41 · market factors 30 Thermo Fisher Scientificof which business quality 60 · market factors 80
ProfitabilityMargins and returns on capital today
38
43
Quality GrowthAre margins and returns improving?
11
31
CashflowEarnings quality: real cash, not paper profit
3
62
Fin. StrengthBalance sheet, leverage, solvency risk
84
60
InvestmentDisciplined investing over empire-building
27
79
Low VolatilityCalm price path (market factor)
50
69
MomentumPrice trend over the last 3–12 months (market factor)
29
83
52W MomentumDistance to the 52-week high (market factor)
7
89
Net IssuanceShare count: buybacks or dilution?
82
97

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyGenetics Generation AdvancementPrice TWD 39.45Thermo Fisher ScientificPrice $665
DCF Models-73%below the priceTWD 10.70-42%below the price$388
Earnings-Based-84%below the priceTWD 6.45-70%below the price$203
Dividend Discount-40%below the priceTWD 23.48n/a
Multiples-66%below the priceTWD 13.61-54%below the price$308
Asset-Based-62%below the priceTWD 15.10-86%below the price$96.29
Growth DCFn/a-50%below the price$334
Economic Profit-71%below the priceTWD 11.41-76%below the price$159
Growth Earnings-66%below the priceTWD 13.25-49%below the price$341
Minimum-84%below the priceTWD 6.45-86%below the price$96.29
Maximum-40%below the priceTWD 23.48-42%below the price$388
Median-66%below the priceTWD 13.25-54%below the price$308
Geometric mean-68%below the priceTWD 12.60-64%below the price$237

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Genetics Generation Advancement: 16 of 16 models see the stock below the current price.

Thermo Fisher Scientific: 24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Genetics Generation Advancement
Price TWD 39.45
Fair Value TWD 13.61
Bear TWD 10.21Bull TWD 17.02
Thermo Fisher Scientific
Price $665
Fair Value $683
Bear $389Bull $887

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Genetics Generation Advancement · Consumer Staples

Quality score37 · bottom 25%
Fair value upside-66% · bottom 25%

Thermo Fisher Scientific · Health Care

Quality score62 · above median
Fair value upside+3% · above median

Bottom line

As of Sep 25, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the more attractively valued of the two: Genetics Generation Advancement trades at TWD 39.45 versus a fair value of TWD 13.61 (-66%), while Thermo Fisher Scientific trades at $665 versus $683 (+3%).

Thermo Fisher Scientific has the higher quality score (62/100).

Open Thermo Fisher Scientific live analysis →
Genetics Generation Advancement · Thermo Fisher Scientific

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Genetics Generation Advancement

Microsoft vs NvidiaApple vs MicrosoftNvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor Manufacturing

Related to Thermo Fisher Scientific

Alphabet Inc Class C vs Meta PlatformsCisco Systems vs NvidiaMicrosoft vs Taiwan Semiconductor ManufacturingApple vs Cisco Systems
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.